Uganda Tuberculosis Implementation Research Consortium

Human Centered Design

Community Health Workers test out a contact tracing prototype developed by IDEO.org with each other

PROJECTS

Human-Centered Design and Communities of Practice to Improve Delivery of Home-based Tuberculosis Contact Investigation in Uganda

HIV TB Stigma

Interrupting HIV and TB stigma in the household during TB contact investigation in Uganda

PEER Health

Partnerships for Enhanced Engagement in Research (PEER) Health

DOT to DAT

From Directly-Observed Therapy to Digital Adherence Technology for TB Treatment

END Childhood TB

Evaluation of Novel Diagnostics for Childhood Tuberculosis

XPEL-TB

The Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care

3HP Options Trial

Options for Delivering Isoniazid-Rifapentine for TB Prevention Trial

ExaCT TB

Evaluating the Impact of Cash Transfers Plus on Tuberculosis Care

TEACH

Theory Informed Education and Counseling Intervention for HIV-TB Treatment Adherence

STOMP

Strategies for Treating Observing Managing and Preventing Tuberculosis

TURN-TB logo

Trace Ultra Result iNsight in TB screening

OUR TEAM

We have a team of individuals from around the world who are dedicated to providing the best possible experience for communities we interact with around Uganda. To learn more about specific team members and the projects they work on, click below!

Learn More

U-TIRC CONTACT

Contact us

Head Office

Uganda Tuberculosis Implementation Research Consortium

Makerere University College of Health Sciences

P.O. Box 21696

Kampala, Uganda

Email:

Phone Number: +256 702 227 558

Employment and Training Opportunities

Walimu is a non-profit organization whose overall goal is to improve the care of hospitalized severely ill patients in Uganda.

WALIMU seeks to hire suitable candidates for the following positions for the Rapid Research in Diagnostics Development for TB (R2D2) study to be based at Kisenyi HC IV, in Kampala. R2D2 study is a multi-center study which seeks to identify and rigorously assess promising early-stage tuberculosis (TB) triage, diagnostic, and drug resistance tests in clinical studies conducted in settings of intended use. Successful candidates will report to the Study Coordinator.